Abbott Reports 2 Percent Dx Growth Amid Flat Overall Q1 Revenues | GenomeWeb

NEW YORK (GenomeWeb) ­– Abbott reported Wednesday morning that first quarter sales in its Diagnostics business grew 2 percent year over year, buoying flat overall revenue growth for the company.

For the three months ended March 31, Abbott reported overall Q1 revenues of $4.89 billion, down a fraction of a percent from Q1 last year, but up 5 percent year over year excluding unfavorable foreign currency effects. The company beat the consensus Wall Street estimate of $4.78 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.